[EFFECT] Oric Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

The SEC has declared Oric Pharmaceuticals' Form S-3 registration statement effective as of June 20, 2025, at 4:00 P.M. The registration statement was filed under file number 333-287949.

Form S-3 is a shelf registration that allows publicly traded companies to register securities for future public offerings. This effectiveness notice indicates that Oric Pharmaceuticals has met SEC requirements and can now proceed with their planned securities offering(s).

This regulatory development suggests that Oric Pharmaceuticals may be positioning itself for potential future capital raising activities, which could include offerings of common stock, preferred stock, debt securities, warrants, or other securities as specified in their registration statement.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 20, 2025 4:00 P.M.

Form:

S-3

CIK:	0001796280
Company Name:	Oric Pharmaceuticals, Inc.
File Number:	333-287949

FAQ

When did ORIC's S-3 registration statement become effective?

ORIC's S-3 registration statement became effective on June 20, 2025 at 4:00 P.M., as indicated in the SEC Notice of Effectiveness.

What is ORIC Pharmaceuticals' CIK number on their S-3 filing?

ORIC Pharmaceuticals' CIK number is 0001796280 as shown on their S-3 registration statement.

What is the file number for ORIC Pharmaceuticals' S-3 registration statement?

The file number for ORIC Pharmaceuticals' S-3 registration statement is 333-287949.

When did ORIC Pharmaceuticals file their EFFECT notice with the SEC?

ORIC Pharmaceuticals filed their EFFECT notice with the SEC on June 28, 2025, indicating the effectiveness of their S-3 registration statement.